Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • 181 W. Boardwalk Drive
  • Suite 202
  • Fort Collins, CO 80525

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2014 10-Q
CIK 0001389870
Fiscal Year End 3/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Business Status Development Stage Company a/o
Incorporated In: CO, USA
Year of Inc. 2006
Employees 2 a/o Jan 01, 2013
Company Officers/Contacts
Bruce Schneider CEO
Jack Riccardi CFO
Company Directors
Bruce Schneider Chairman
Michael E. Kamarck
Company Notes
  • Formerly=Across America Financial Services, Inc. until 7-2009
Service Providers
Accounting/Auditing Firm
Hein & Associates LLP
1999 Broadway Ste 4000
Denver, CO, 80202
United States

Legal Counsel
Fox Rothschild LLP
10 Sentry Parkway
Suite 200
PO Box 3001
Blue Bell, PA, 19422
United States

Investor Relations Firm
Tiberend Strategic Advisors, Inc.
35 W. 35th Street, 11th Floor
New York, NY, 10001-0080
United States

OMBP Security Details
Share Structure
Market Value1 $1,001,108 a/o Sep 22, 2017
Authorized Shares 200,000,000 a/o Sep 22, 2017
Outstanding Shares 50,055,382 a/o Sep 22, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Corporate Stock Transfer, Inc.
Shareholders of Record 431 a/o Jun 16, 2014
Short Selling Data
Short Interest 45 (100%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security